Omalizumab and the risk of malignancy: Results from a pooled analysis

The environment and disease: association or causation?

Austin Bradford Hill · Journal of the Royal Society of Medicine · 2015 · 7.3K citations · Full text

Environmental Health, Environmental Epidemiology, Environmental Factors +3

The Environment and Disease: Association or Causation?

Austin Bradford Hill · Proceedings of the Royal Society of Medicine · 1965 · 6.8K citations · Full text

Environmental Health, Environmental Epidemiology, Environmental Factors +3

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

Asthma, Allergy, Allergy Medicine +9

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

William W. Busse, Wayne J. Morgan, Peter J. Gergen et al. · New England Journal of Medicine · 2011 · 863 citations · Full text